Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome
Authors:
- F LepratFLF Leprat
- A TabarinATA Tabarin
Open Access
- 1 August 1999
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 141 (2) , 117-121
Abstract
The best approach to radioiodine dose selection in the treatment of Graves' hyperthyroidism remains highly controversial. The formula to calculate the individual dose of (131)I to be delivered has been used for half a century and takes into account the thyroid mass, the effective half-life and the maximum uptake of (131)I. The objective of the present study was to evaluate the accuracy of this formula by determining the relationship between the administered dose of (131)I calculated to deliver a target dose of 50Gy to the thyroid and the actual exact organ dose. We further analyzed if therapeutic success, defined by euthyroidism following the individually calculated dose, can be predicted by different pretreatment parameters and particularly by organ dose. One hundred patients with a first episode of Graves' disease and who had received optimal thyroid irradiation after precise dosimetry were retrospectively reviewed. The patients were categorized according to their thyroid function (plasma free thyroxine (T(4)) serum concentration) as eu-, hyper- or hypothyroid during and 1 year after treatment. The relationship between the administered dose and organ dose was assessed by simple regression. We compared free T(4), free tri-iodothyronine, thyroid weight, the number of patients with antithyroperoxidase antibodies and TSH receptor autoantibodies, 24h urinary iodine excretion, (131)I uptake, and the exact dose of (131)I delivered to the thyroid as pretreatment variables. Although we found a correlation between administered dose (mCi) and organ dose (Gy) (r=0.3, P=0.003), the mean coefficient of variation for organ dose was 45%. Individualized radioiodine therapy enabled euthyroidism in 26% of patients and failed in 74% of patients (33% had persistent or recurrent hyperthyroidism and 41% permanent hypothyroidism). (131)I uptake was significantly higher in the hyperthyroidism group in comparison with the euthyroid group. However, organ dose and other pretreatment variables did not differ among the three groups. In conclusion, these results confirm the low performance of individual dosimetry using what are established ratios, since the delivered dose to the gland, although correlated to the intended dose, is highly variable. The finding that other usual pretreatment variables are not different between groups, gives little hope for improving the way of calculating the ideal dose of radioiodine. We suggest to those not yet ready to give a standard or an ablative dose for Graves' hyperthyroidism that they abandon this way to calculate the (131)I dose.Keywords
This publication has 8 references indexed in Scilit:
- The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' diseaseClinical Endocrinology, 1997
- The development of transient hypothyroidism after iodine‐131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosisClinical Endocrinology, 1997
- Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?Clinical Endocrinology, 1995
- Treatment with Propylthiouracil before Radioactive Iodine Therapy Is Associated with a Higher Treatment Failure Rate Than Therapy with Radioactive Iodine Alone in Graves' DiseaseThyroid®, 1995
- Calculation of the ideal dose of radioiodine for treatment of thyroid diseaseEuropean Journal of Endocrinology, 1995
- Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity*. Results from a prospective, randomized, multicentre studyEuropean Journal of Clinical Investigation, 1995
- Current Trends in the Management of Graves' Disease*The Journal of Clinical Endocrinology & Metabolism, 1990
- TWO MECHANISMS FOR HYPOTHYROIDISM AFTER 131I THERAPYThe Lancet, 1976